Mike Doustdar

What are the compounders doing in terms of your business right now?

What I can tell you is that we have been quite surprised on how the compounding has gotten started.

Right.

Taking an API, the raw ingredient of a medication that has not been approved by FDA, and injecting that into human beings is something very far from what we have been educated in this industry.

So we will continue to lobby for the administration and what have you that this is simply not right.

I will not get into the details of the deal as you could imagine.

We will wait and see what the deal looks like later this week.

Mike, great to see you.

Thank you very much for stopping by to see us.

We really appreciate it.

And thank you for inviting us to the headquarters.

We really appreciate that as well.

Mike Duster, the CEO of Novo Nordisk.